High Potency APIs Video

News
Article

A conversation with Kevin Brady of Alkermes about how high potency APIs are changing the way drugs are developed and manufactured in terms of process, equipment and regulations, including a case study that demonstrates the effective scale up or manufacture of a drug with a highly potent API.


A conversation with Kevin Brady of Alkermes about how high potency APIs are changing the way drugs are developed and manufactured in terms of process, equipment and regulations, including a case study that demonstrates the effective scale up or manufacture of a drug with a highly potent API.

Recent Videos
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Jens Schmidt, associate director MSAT at Lonza
Roger Viney, PhD, chief commercial officer for ICE Pharma
Behind the Headlines, episode 7
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

FDA Approves First Generics of Rivaroxaban Tablets

Patrick Lavery
March 12th 2025
Article

Rivaroxaban, long known under the brand name Xarelto, is an anticoagulant, a classification that is among the most-prescribed medications in the United States.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Approves Evrysdi Tablet from Roche for Spinal Muscular Atrophy

Feliza Mirasol
February 17th 2025
Article

The approval makes Evrysdi the first and only tablet for treating spinal muscular atrophy.

Drug Solutions Podcast: The Biosimilars Landscape

Drug Solutions Podcast: The Biosimilars Landscape

Feliza Mirasol
January 31st 2024
Podcast

In this episode of the Drug Solutions Podcast, industry experts give an overview of the biosimilars market and discuss factors affecting not only their manufacture, but their upstake in the market as well.

Hand of young man with pill, closeup. Image Credit: ©Africa Studio - stock.adobe.com

Evolving Approaches to Taste Masking

Cynthia A. Challener
February 7th 2025
Article

Increasing API and formulation complexity and new delivery strategies are driving innovations in taste-masking.

Pile of colorful medicine pills and capsules in blister packs | Image Credit: © ImageFlow - stock.adobe.com

Meeting Secondary Packaging Challenges of Innovative Delivery Systems for Biologics

Joe Compton
February 6th 2025
Article

Rapid market growth in biologics is helping the packaging market expand as well, but the complex nature of biologics and the desire for personalized therapies present unique hurdles to make packaging solutions cost-effective and safe for patients.